WO2006079896A3 - Stable polyol formulations of oxazolidinone antibacterial agents - Google Patents
Stable polyol formulations of oxazolidinone antibacterial agents Download PDFInfo
- Publication number
- WO2006079896A3 WO2006079896A3 PCT/IB2006/000117 IB2006000117W WO2006079896A3 WO 2006079896 A3 WO2006079896 A3 WO 2006079896A3 IB 2006000117 W IB2006000117 W IB 2006000117W WO 2006079896 A3 WO2006079896 A3 WO 2006079896A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- gel formulations
- oxazolidinone
- antibacterial agents
- present
- oxazolidinone antibacterial
- Prior art date
Links
- 238000009472 formulation Methods 0.000 title abstract 6
- 239000000203 mixture Substances 0.000 title abstract 6
- IZXIZTKNFFYFOF-UHFFFAOYSA-N 2-Oxazolidone Chemical compound O=C1NCCO1 IZXIZTKNFFYFOF-UHFFFAOYSA-N 0.000 title abstract 4
- 229920005862 polyol Polymers 0.000 title abstract 3
- 150000003077 polyols Chemical class 0.000 title abstract 3
- 239000003242 anti bacterial agent Substances 0.000 title 1
- 229940079593 drug Drugs 0.000 abstract 3
- 239000003814 drug Substances 0.000 abstract 3
- 230000003115 biocidal effect Effects 0.000 abstract 2
- 239000002904 solvent Substances 0.000 abstract 2
- 241000192125 Firmicutes Species 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- TYZROVQLWOKYKF-ZDUSSCGKSA-N linezolid Chemical compound O=C1O[C@@H](CNC(=O)C)CN1C(C=C1F)=CC=C1N1CCOCC1 TYZROVQLWOKYKF-ZDUSSCGKSA-N 0.000 abstract 1
- 229960003907 linezolid Drugs 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000002562 thickening agent Substances 0.000 abstract 1
- 238000011200 topical administration Methods 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Stable gel formulations of oxazolidinone antibiotic drugs, such as linezolid, are provided which are suitable for topical administration. Gel formulations of the present invention comprise an oxazolidinone antibiotic drug solubilized in a polyol solvent system including a polyol solvent, a thickening agent, and water. The oxazolidinone drug remains solubilized in gel formulations of the present formulation for at least 3 hours at a temperature from 15°C to 30°C. Also provided are methods of topically administering gel formulations of the present invention to treat or prevent infection by gram-positive bacteria.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US64756105P | 2005-01-27 | 2005-01-27 | |
US60/647,561 | 2005-01-27 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2006079896A2 WO2006079896A2 (en) | 2006-08-03 |
WO2006079896A3 true WO2006079896A3 (en) | 2007-01-11 |
Family
ID=36740872
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB2006/000117 WO2006079896A2 (en) | 2005-01-27 | 2006-01-17 | Stable polyol formulations of oxazolidinone antibacterial agents |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2006079896A2 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2275061A1 (en) | 2009-07-15 | 2011-01-19 | Otos Tech Co., Ltd. | Welding helmet including anti-blinding device to selectively and conveniently control welding operation and grinding operation |
GB2487773B (en) * | 2011-02-04 | 2014-09-17 | Aidance Skincare & Topical Solutions Llc | Topical antibiotic formulations |
WO2021184339A1 (en) * | 2020-03-20 | 2021-09-23 | Merck Sharp & Dohme Corp. | Oxazolidinone compound and methods of use thereof as an antibacterial agent |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1989007436A1 (en) * | 1988-02-18 | 1989-08-24 | The Upjohn Company | Minoxidil gel |
WO1994007478A1 (en) * | 1992-10-06 | 1994-04-14 | The Upjohn Company | Topical pharmaceutical compositions |
WO2002030395A1 (en) * | 2000-10-10 | 2002-04-18 | Pharmacia & Upjohn Company | Topical antibiotic composition for treatment of eye infection |
WO2003030906A1 (en) * | 2001-10-11 | 2003-04-17 | Pharmacia & Upjohn Company | Treating infections by administration of oxazolidinones to the skin |
-
2006
- 2006-01-17 WO PCT/IB2006/000117 patent/WO2006079896A2/en not_active Application Discontinuation
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1989007436A1 (en) * | 1988-02-18 | 1989-08-24 | The Upjohn Company | Minoxidil gel |
WO1994007478A1 (en) * | 1992-10-06 | 1994-04-14 | The Upjohn Company | Topical pharmaceutical compositions |
WO2002030395A1 (en) * | 2000-10-10 | 2002-04-18 | Pharmacia & Upjohn Company | Topical antibiotic composition for treatment of eye infection |
WO2003030906A1 (en) * | 2001-10-11 | 2003-04-17 | Pharmacia & Upjohn Company | Treating infections by administration of oxazolidinones to the skin |
Also Published As
Publication number | Publication date |
---|---|
WO2006079896A2 (en) | 2006-08-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2004062601A3 (en) | Antibacterial agents | |
MX2009005603A (en) | Antibacterial polycyclic urea compounds. | |
WO2006087543A8 (en) | Antibacterial piperidine derivatives | |
WO2008020229A3 (en) | Antibacterial pyrrolecarboxamides | |
WO2008020227A3 (en) | Antibacterial pyrrolecarboxamides | |
TWI327573B (en) | 6-11 bicyclic ketolide derivatives | |
BR0307898A (en) | Ophthalmic antibiotic drug formulations containing a cyclodextrin compound and cetyl pyridinium chloride | |
AU2003241345A1 (en) | Use of mastic and its components for the control of microbial infections | |
PT806941E (en) | LIPOSOMIC ANTI-BACTERIAL COMPOSITIONS OF LOW RIGIDITY | |
WO2007071965A3 (en) | Antibacterial pyrrolopyridines, pyrrolopyrimidines, and pyrroloazepines | |
BRPI0508933A (en) | compositions for topical delivery | |
IL189017A0 (en) | 8-methoxy-9h-isothiazolo[5,4-b]quinoline-3,4-diones and related compounds as anti-effective agents | |
WO2005000863A3 (en) | 6, 11-4c-bicyclic 9a-azalide derivatives | |
WO2004087728A3 (en) | 6,11-3c-bicyclic 9a-azalide derivatives | |
WO2004096823A3 (en) | Novel ketolide derivatives | |
WO2009043987A9 (en) | Antibiotic compositions containing essential oils, prophylaxis and treatment of nosocomial diseases | |
AP2003002942A0 (en) | New derivatives of oxazolidinones as bacterial agents | |
CA2483875A1 (en) | 6,11 bicyclic erythromycin derivatives | |
WO2006079896A3 (en) | Stable polyol formulations of oxazolidinone antibacterial agents | |
AR064152A1 (en) | ANTIBACTERIAL QUINOLINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND PREPARATION METHOD. | |
WO2006063039A3 (en) | 3, 6-bicyclolides | |
WO2015112977A1 (en) | Antimicrobial formulations and applications thereof | |
EP1114826A3 (en) | Novel antibacterial and prokinetic macrolides | |
WO2007044927A3 (en) | 6, 11-bridged tricyclic macrolides | |
BRPI0514898A (en) | Methods for Transmembrane Treatment and Prevention of Otitis Media |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
DPE2 | Request for preliminary examination filed before expiration of 19th month from priority date (pct application filed from 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
122 | Ep: pct application non-entry in european phase |
Ref document number: 06701066 Country of ref document: EP Kind code of ref document: A2 |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 6701066 Country of ref document: EP |